Tsaliki, M.; Kurien, B.T.; Cavett, J.; Ice, J.A.; Koelsch, K.A.; Scofield, R.H.
Evaluating Anti-CCL25 as a Therapeutic Strategy to Disrupt Foci Formation in a Spontaneous Murine Model of Sjögren’s Disease. Int. J. Mol. Sci. 2025, 26, 8802.
https://doi.org/10.3390/ijms26188802
AMA Style
Tsaliki M, Kurien BT, Cavett J, Ice JA, Koelsch KA, Scofield RH.
Evaluating Anti-CCL25 as a Therapeutic Strategy to Disrupt Foci Formation in a Spontaneous Murine Model of Sjögren’s Disease. International Journal of Molecular Sciences. 2025; 26(18):8802.
https://doi.org/10.3390/ijms26188802
Chicago/Turabian Style
Tsaliki, Martha, Biji T. Kurien, Joshua Cavett, John A. Ice, Kristi A. Koelsch, and Robert Hal Scofield.
2025. "Evaluating Anti-CCL25 as a Therapeutic Strategy to Disrupt Foci Formation in a Spontaneous Murine Model of Sjögren’s Disease" International Journal of Molecular Sciences 26, no. 18: 8802.
https://doi.org/10.3390/ijms26188802
APA Style
Tsaliki, M., Kurien, B. T., Cavett, J., Ice, J. A., Koelsch, K. A., & Scofield, R. H.
(2025). Evaluating Anti-CCL25 as a Therapeutic Strategy to Disrupt Foci Formation in a Spontaneous Murine Model of Sjögren’s Disease. International Journal of Molecular Sciences, 26(18), 8802.
https://doi.org/10.3390/ijms26188802